[1]
Laurenti, L. et al. 2013. CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE. Mediterranean Journal of Hematology and Infectious Diseases. 5, 1 (May 2013), e2013031. DOI:https://doi.org/10.4084/mjhid.2013.031.